Coherent (NASDAQ:COHR) has been given a $325.00 price target by Barclays in a research note issued to investors on Thursday, MarketBeat Ratings reports. The firm presently has an “overweight” rating on the scientific and technical instruments company’s stock. Barclays’ price objective points to a potential upside of 55.05% from the company’s current price.

A number of other brokerages have also recently commented on COHR. BidaskClub raised Coherent from a “hold” rating to a “buy” rating in a research report on Thursday, January 18th. Zacks Investment Research cut Coherent from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Stifel Nicolaus upped their price target on Coherent from $290.00 to $330.00 and gave the company a “buy” rating in a research report on Wednesday, November 8th. Benchmark upped their price target on Coherent from $290.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, November 8th. Finally, Needham & Company LLC upped their price target on Coherent from $270.00 to $330.00 and gave the company a “buy” rating in a research report on Wednesday, November 8th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $312.22.

Coherent (COHR) opened at $209.61 on Thursday. Coherent has a 1 year low of $179.60 and a 1 year high of $329.00. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.14 and a current ratio of 3.18. The company has a market capitalization of $5,300.00, a price-to-earnings ratio of 23.71 and a beta of 0.65.

Coherent (NASDAQ:COHR) last issued its quarterly earnings results on Wednesday, February 7th. The scientific and technical instruments company reported $3.54 EPS for the quarter, beating analysts’ consensus estimates of $3.52 by $0.02. Coherent had a return on equity of 29.82% and a net margin of 11.79%. The firm had revenue of $477.60 million for the quarter, compared to analysts’ expectations of $474.21 million. During the same quarter in the prior year, the firm earned $2.57 EPS. The business’s revenue for the quarter was up 38.0% compared to the same quarter last year. sell-side analysts forecast that Coherent will post 15.56 earnings per share for the current fiscal year.

Coherent announced that its Board of Directors has initiated a share repurchase program on Wednesday, February 7th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the scientific and technical instruments company to buy shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

In related news, EVP Paul F. Sechrist sold 1,372 shares of the stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $300.00, for a total transaction of $411,600.00. Following the sale, the executive vice president now owns 2,497 shares of the company’s stock, valued at approximately $749,100. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen A. Skaggs sold 500 shares of the stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $308.97, for a total value of $154,485.00. Following the sale, the director now directly owns 11,000 shares in the company, valued at approximately $3,398,670. The disclosure for this sale can be found here. Insiders have sold a total of 9,569 shares of company stock worth $2,898,201 in the last three months. 1.40% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Coldstream Capital Management Inc. lifted its holdings in Coherent by 3.1% during the 2nd quarter. Coldstream Capital Management Inc. now owns 1,010 shares of the scientific and technical instruments company’s stock worth $227,000 after purchasing an additional 30 shares in the last quarter. Oakbrook Investments LLC lifted its holdings in Coherent by 7.0% during the 4th quarter. Oakbrook Investments LLC now owns 2,435 shares of the scientific and technical instruments company’s stock worth $687,000 after purchasing an additional 160 shares in the last quarter. Dynamic Technology Lab Private Ltd increased its stake in Coherent by 10.3% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 2,060 shares of the scientific and technical instruments company’s stock worth $485,000 after acquiring an additional 193 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. increased its stake in Coherent by 12.8% in the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,980 shares of the scientific and technical instruments company’s stock worth $701,000 after acquiring an additional 337 shares during the last quarter. Finally, UBS Asset Management Americas Inc. increased its stake in Coherent by 1.7% in the 4th quarter. UBS Asset Management Americas Inc. now owns 20,274 shares of the scientific and technical instruments company’s stock worth $5,722,000 after acquiring an additional 342 shares during the last quarter. 96.63% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Coherent (COHR) Given a $325.00 Price Target by Barclays Analysts” was reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.dailypolitical.com/2018/02/10/coherent-cohr-given-a-325-00-price-target-by-barclays-analysts.html.

Coherent Company Profile

Coherent, Inc is a photonics manufacturer. The Company is engaged in designing, manufacturing, servicing and marketing of lasers and related accessories for a range of scientific, commercial and industrial applications. It operates through two segments: Specialty Lasers and Systems (SLS) and Commercial Lasers and Components (CLC).

Analyst Recommendations for Coherent (NASDAQ:COHR)

Receive News & Ratings for Coherent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coherent and related companies with MarketBeat.com's FREE daily email newsletter.